Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Global Clinical Trial Patient Recruitment Services Market by Therapeutic Areas (Anti-Infective, Cardiovascular, Central Nervous System), Phase (Phase I, Phase II, Phase Ill), Age Group - Forecast 2024-2030" report has been added to ResearchAndMarkets.com's offering.
The latest research publication on the Clinical Trial Patient Recruitment Services Market has been released, offering an in-depth analysis with forecasts up to 2030, imperative for industry stakeholders and investors.
Segmented by therapeutic areas such as Anti-Infective, Cardiovascular, Central Nervous System, and several other categories, the study provides an extensive market outlook, dissecting crucial aspects ranging from technology trends to regulatory frameworks.
Market Insights and Development Strategies
The report offers a rich tapestry of market intelligence, covering key points such as market penetration and competitive intelligence. Insights gathered through the FPNV Positioning Matrix and Market Share Analysis provide a basis for strategic planning, highlighting diverse opportunities for market development.
With an estimated market size of USD 1.16 billion in 2023 and expected growth to reach USD 2.22 billion by 2030, the comprehensive evaluation of market dynamics explores innovative profiles of key leaders and their contributions to the industry's evolution.
Comprehensive Therapeutic Area Assessment
The scalable nature of different therapeutic areas is underscored, capturing the sector's robust demand across a spectrum encompassing Anti-Infective to Central Nervous System. The report also spans age group analysis and different phases of clinical trials, including Phase I, Phase II, Phase III, and Phase IV, offering stakeholders detailed strategic intelligence.
Geographical Market Diversity
Vital revenue forecasts for prominent geographic regions, including Americas, Asia-Pacific, and Europe, Middle East & Africa, are unfolded, spotlighting regions such as the United States and emerging markets like India and China. Detailed coverage of these areas fuels informed decision-making for global market participants.
Vendor Landscape & Evolving Trends
- Key Company Profiles: An exhaustive roster of market participants is examined, showcasing the strategic imperatives of industry frontrunners.
- Market Segmentation: A thorough analysis of segments provides clarity on market trends and revenue generation potentials.
The publication articulates strategic insights and granular analysis, pivotal for tapping into high-growth niches and comprehending the competitive landscape of the Clinical Trial Patient Recruitment Services Market. The inquiry into the market's future trajectory is now accessible, elucidating growth prospects and market dynamics with precision.
Anticipating the directions of technological advancements and monitoring the pulse of market shifts, the report is an indispensable tool for businesses aiming to harness the full potential of the Clinical Trial Patient Recruitment Services Market.
The report stands as a guiding light for entities aiming at fortifying their market presence and seeking detailed intelligence on investment opportunities, innovative advancements, and the competitive canvas of the Clinical Trial Patient Recruitment Services Market.
Key Attributes:
Report Attribute | Details |
No. of Pages | 198 |
Forecast Period | 2024 - 2030 |
Estimated Market Value (USD) in 2024 | $1.27 Billion |
Forecasted Market Value (USD) by 2030 | $2.22 Billion |
Compound Annual Growth Rate | 9.6% |
Regions Covered | Global |
Market Overview
Drivers
- Increasing number of clinical trials all over the globe
- Rapid adoption of patient recruitment sevices by clinical trial organizations
- Government support for patient engagement programs
Restraints
- Concern associated with substantial cost of the PR services
Opportunities
- Ongoing research and development activities in pharmaceuticals and biotechnology sector
- Collaborative efforts to enhance the growth of the clinical trials patient recruitment services
Challenges
- Lack of awareness about clinical trials in patients
- Market Segmentation Analysis
Companies Mentioned
- Antidote Technologies, Inc.
- AutoCruitment LLC by QHP Capital
- BBK Worldwide, LLC
- Biorasi, LLC
- Clara Health by M&B Sciences Inc.
- Clariness GmbH
- Clinical Site Services (CCSi)
- Conduent, Inc.
- Elligo Health Research
- IQVIA Inc. by Q2 Metrics
- Matthews Media Group Inc.
- MESM Ltd by VWR
- PatientEvolution
- PPD Inc. by Thermo Fisher Scientific
- Science 37, Inc. by LifeSci Acquisition II Corp.
- Syneos Health
- Trialbee AB
- Trialfacts
- Veristat
- Worldwide Clinical Trials
For more information about this report visit https://www.researchandmarkets.com/r/jj1lo9
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment